Similar to our results, Tang et al. reported that serum S1P levels in lung cancer patients were about 2-fold higher than those in the normal population, as well as about 2-fold higher during radiotherapy than during non-radiotherapy [47], suggesting that modest changes in S1P are sufficient to induce pathological effects in vivo. Here, MBTPS1 is linked to lung carcinoma.